These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 4660855)
1. [Clinical effects of rifampicin applied every other day for severe cavitary pulmonary tuberculosis]. Hashimoto T; Takahashi S; Kasai K; Tamura M; Yamada M Kekkaku; 1972 Aug; 47(8):273-7. PubMed ID: 4660855 [No Abstract] [Full Text] [Related]
2. [Clinical study on rifampicin applied every other day for severe cavitary pulmonary tuberculosis (author's transl)]. Kitatani F; Fujimoto S; Asahi T; Konishiike J; Sera Y Kekkaku; 1974 May; 49(5):133-8. PubMed ID: 4408937 [No Abstract] [Full Text] [Related]
3. [Late results of treatment of chronic pulmonary tuberculosis with rifampicin]. Lachowicz E; Polaczek E; Araszkiewicz W; Kozakow H; Pszonicka A; Styszewska H; Janowiec M; Grabowska R Gruzlica; 1973 Jul; 41(7):781-7. PubMed ID: 4730979 [No Abstract] [Full Text] [Related]
4. [Rifampicin in the treatment of chronic pulmonary tuberculosis. Preliminary report]. Pacheco CR; Cordero O; López-Malagón S; Sierra D; De Jesús Pacheco M; Vázquez E Gac Med Mex; 1973 Jun; 105(6):541-7. PubMed ID: 4731993 [No Abstract] [Full Text] [Related]
5. [Early results of treatment of patients with chronic pulmonary tuberculosis with rifampicin]. Böszörmenyi M Gruzlica; 1974 May; 42(5):407-10. PubMed ID: 4464228 [No Abstract] [Full Text] [Related]
6. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli]. Anastasatu C; Sibila S Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363 [No Abstract] [Full Text] [Related]
8. [Comparison of therapeutic effects of rifampicin 450 mg daily and 600 mg three times weekly on the previously treated pulmonary tuberculosis patients]. Yamamoto M; Mizutani A; Nakamura H; Hirose H; Nagata A Kekkaku; 1973 May; 48(5):197-202. PubMed ID: 4732658 [No Abstract] [Full Text] [Related]
9. [Preliminary clinical observations on the use of Rifampicin in chronic cavitary pulmonary tuberculosis previously treated with and resistant to other drugs]. Mauro G Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):461-6. PubMed ID: 5309059 [No Abstract] [Full Text] [Related]
10. [Clinical results of retreatment using rifampicin for more than 12 months for pulmonary tuberculosis (author's transl)]. Urakami E; Nagasawa S Kekkaku; 1973 Sep; 48(9):411-6. PubMed ID: 4772413 [No Abstract] [Full Text] [Related]
11. [Comparison of blood concentration of rifampicin between administration before and after breakfast]. Tsukamura M; Yokouchi J; Miwa T; Koike K Kekkaku; 1972 Apr; 47(4):69-73. PubMed ID: 5073928 [No Abstract] [Full Text] [Related]
12. [Experience with endobronchial and local use of rifampicin in tuberculosis]. Abdurashitova MV; Stoianovskiĭ EA; Fok AIa Probl Tuberk; 1976 Jan; (l):35-8. PubMed ID: 995905 [No Abstract] [Full Text] [Related]
13. [Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results]. Cornudella R; Garcia-Besada JA; Castellano A Rev Clin Esp; 1972 Jul; 126(1):59-64. PubMed ID: 5080189 [No Abstract] [Full Text] [Related]
14. [Early results of sputum-positive patients with newly-detected pulmonary tuberculosis with rifampicin combined with isoniazid and SM (preliminary report)]. Ropek M; Szymański A; Banaszkiewicz H; Chetkowski A; Czaplińska-Jóźwiak E; Dabrowska-Solecka Z; Ignaczak J; Kondratowicz W; Królikowska H; Pawlik J; Pawlowska I; Sliwińska M; Szuster I; Szymánska W Gruzlica; 1973 Jul; 41(7):777-80. PubMed ID: 4730978 [No Abstract] [Full Text] [Related]
15. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis]. Donomae I; Fujita S; Gomi J; Hibino S; Horai Z Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166 [No Abstract] [Full Text] [Related]
16. [Complex therapy of newly detected patients with destructive pulmonary tuberculosis using rifampicin and tuberculin]. Reĭle EE; Polushkina EE Probl Tuberk; 1987; (2):22-5. PubMed ID: 3575271 [No Abstract] [Full Text] [Related]
17. [Treatment of pulmonary tuberculosis of native Black Africans a chemotherapeutic regime including rifampicin (apropos of 75 patients)]. Ayad M; Hane A; Kane PA Dakar Med; 1980; 25(1):65-74. PubMed ID: 7460740 [No Abstract] [Full Text] [Related]
18. Rifampicin in the treatment of resistant pulmonary tuberculosis. Wäre M; Lorenzen J Scand J Respir Dis Suppl; 1970; 72():113-9. PubMed ID: 4990617 [No Abstract] [Full Text] [Related]
19. [Relation between the efficacy of complex therapy of patients with destructive pulmonary tuberculosis and the duration of rifampicin administration]. Sagalovich VIa; Manzhikova SR Probl Tuberk; 1984 Oct; (10):51-4. PubMed ID: 6514699 [No Abstract] [Full Text] [Related]
20. [Investigation on failures in the treatment of pulmonary tuberculosis with rifampicin. Tuberculosis Research Committee. RYOKEN]. Kekkaku; 1984 Feb; 59(2):91-104. PubMed ID: 6431172 [No Abstract] [Full Text] [Related] [Next] [New Search]